REMDESIVIR
Remdesivir was given to Frank within hours of arrival to Canberra Hospital
Canberra Hospital administered remdesivir:
without seeking or obtaining informed consent, or any consent at all, from his wife and next of kin, Nada;
without any advance notice to his next of kin;
without warning of adverse effects or risks;
without warning it can cause death; and
contrary to Australian guidelines; and
Despite:
hospital records that says “not for remdesivir” eight (8) times; and
Australian guidelines that states remdesivir is not for patients on mechanical ventilation.
Remdesivir is a poison
A poison is a substance that can cause death or injury. Remdesivir is a drug that has a documented death rate of 53.1%, among many other adverse effects such as kidney and liver damage.
Definition of poison:
Oxford Languages: A substance that is capable of causing the illness or death of a living organism when introduced or absorbed
Wikipedia: In biology, poisons are substances that can cause death, injury or harm to organs, tissues, cells, and DNA usually by chemical reactions or other activity on the molecular scale, when an organism is exposed to a sufficient quantity. In a metaphorical broader use of term it may refer to any thing deemed harmful.
dictionary.com: Poison, toxin, venom are terms for any substance that injures the heath or destroys life when absorbed into the system, especially of a higher animal.
Mirriam-Webster: The meaning of POISON is a substance that through its chemical action usually kills, injuries, or impairs an organism. Something destructive or harmful.
Remdesivir was administered in secret:
Doctors administered a drug that fulfils the description of a poison without any notice or consent. Frank’s wife Nada was verbally advised Frank was given “a round of remdesivir” 14 days after it was given to Frank - after the poison had done its damage to his body, and set him on the path to certain death.
Drug Trials & Reports
Remdesivir: Risk Versus Benefits Assessment
Several reports undertaken into the adverse events of remdesivir conclude remdesivir causes a long list of adverse effects, the most critical being a 53% mortality rate. Remdesivir also causes kidney and liver injury.
In contrast, following a drug trial in February 2020, the only reported benefit remdesivir offered was a possible reduction in hospitalisation by 4 days. That report stated deaths occurred from remdesivir during the drug trial, however the mortality statistics were ignored, and mortality information kept from the world.
In consideration of risk versus benefit, it is incomprehensible any doctor would elect to inject a toxic poison that leads to 53% death, and/or kidney and liver injury where the only benefit may be a reduction of 4 days in hospital.
A poison is a substance that can cause death or injury. Remdesivir causes injury and death. Remdesivir is a poison.
Frank died with almost all of the published adverse effects of remdesivir, including death, multi organ failure, kidney failure, acute kidney injury, deep vein thrombosis, bruising and swelling to his face, body, lips and eyes.
Benefits of Remdesivir
BENEFIT: 4 days less in hospital
Following a drug trial for covid in February 2020, the only reported benefit of remdesivir is that it may reduce hospitalisation from 15 days to 11 days.
Mortality that resulted in the drug trail was ignored. As such, an entirely false representation of remdesivir was issued to the world.
In October 2020 The World Health Organisation (WHO) said remdesivir had “little or no effect in preventing death from COVID-19 or reducing time in hospital.”
Adverse Effects of Remdesivir
ADVERSE EFFECTS: Death, multi-organ failure, liver failure, kidney injury, +++++
The US National Institutes of Health (NIH) National Library of Medicine provides several remdesivir drug trial reports on its website. Links to the referenced reports are provided below.
On 22 May 2020 Drugs In Context (DIC) published a report titled“The journey of remdesivir: from Ebola to COVID-19”. The report was completed on 14 April 2020. The report outlines results of four drugs trialled to treat ebola. Remdesivir resulted in the highest death rate of the four drugs, with a death rate of 53.1%.
Page 4 the report states, “At day 28, mortality rates were: remdesivir (53.1%)”
NIAID was involved in, and provided funding for, the ebola drug trials, and as such was aware of the 53% dealth rate of remdesivir.
On 22 July 2020 Biomed Pharmacother published a report titled, “Safety profile of the antiviral drug remdesivir: An update”. The report provides a list of adverse events of remdesivir and the number of events (shown as a percentage below):
increased hepatic enzyme 25% (hepatitis or liver disease);
respiratory failure 4%;
pneumothorax 4% (collapsed lung - air leaks into the space between lungs and chest wall];
hypotension: 8% (high blood pressure);
atrial fibrillation 6% (irregular heart rate - heart’s upper chambers beat out of coordination with the lower chamber);
cardiac arrest 1%;
renal impairment 8% [kidneys lose ability to remove waste);
acute kidney injury 6%;
hematuria 4% (blood in urine); and
constipation, nausea, diarrhea, and gastroparesis.
The report also states, “Other adverse effects. Transient rise in serum amylase was reported in an Ebola-infected patient treated with remdesivir. Grein et al.’s study mentioned rash, multiple-organ-dysfunction syndrome, deep-vein thrombosis, delirium, septic shock, pyrexia as adverse events occurred in remdesivir recipients. Adverse events related to hematologic, circulatory, endocrine and other systems were also detected in the remdesivir group in the RCT in China.”
On 24 October 2020 Cureus published a report titled “Cardiac Adverse Events with Remdesivir in COVID 19 Infection”. The report states “Adverse effects are common with remdesivir, but few studies exist that focus on remdesivir and its effects on the cardiovascular system. Out of a study of 53 patients receiving remdesivir, 32 patients (60%) experienced adverse events during follow-up. These adverse events were increased hepatic enzymes, diarrhea, rash, renal impairment, and hypotension. Adverse events were more common for those on mechanical ventilation compared to those that were not.”
Queensland Health issued a document titled “Patient Information Remdesivir (Veklury)” which states remdesivir can cause swelling of the face, lips, tongue and other parts ofd the body, and severe skin rash including, itching and hives and nausea and vomiting.
Remdesivir given to Frank on Day 1
Canberra Hospital Record: “Treated with remdesivir… 20/9, 21/9”
Canberra Hospital medical records of 28 September 2021 states Frank was given remdesivir on 20 September 2021, which was the date of Frank’s admission to hospital.
On 20 September 2021 Frank:
arrived at Queanbeyan District Hospital at 10.33am;
was discharged from Queanbeyan Hospital at about 3.30pm with a diagnosis of sepsis;
was transferred to Canberra Hospital at about 4.00pm;
was given the poison remdesivir within hours of arrival to Canberra Hospital, despite there being no diagnosis of “covid” on Queanbeyan Hospital discharge records.
Despite 7 phones calls made to Canberra Hospital on 20 September, doctors refused to inform Nada of their decision to inject her husband with a poison that has a documented death rate of 53.1%.
Frank was given remdesivir despite Canberra Hospital’s medical records that says “not for remdesivir” eight (8) times.
Frank’s wife was verbally advised Frank was given a “round of remdesivir” on Monday 4 October 2021,
14 days after it was given to Frank,
after the damage was already done to his body. Nada immediately relayed that information in a text to Frank’s GP.
Nada was aware of remdesivir.
Nada would never have given consent to that poison being given to her husband.
UNVAXED
Canberra Hospital records state Frank was “Not vaccinated” 19 times.
While both Queanbeyan and Canberra Hospitals refused to seek any form of consent for treatments, the primary information Queanbeyan Hospital sought from Frank’s wife was, “Is Frank vaccinated?”.
The information “not vaccinated” was then repeated every day on Frank’s hospital progress notes.
Frank was given remdesivir during the government’s big drive to reach its 80% vaccination target. Daily TV news reported the total NSW vaccination rates in relation to the 80% target. Immediately following vaccination rates, the number of daily hospital covid deaths were reported. In October 2021 the daily hospital death rate in NSW was 10.
Frank’s death was reported on TV news as an “unvaccinated” covid death. The TV news refused to report Frank was given remdesivir - a poison that has a 53% death rate.
UNVAXED DECISION
Frank was not vaccinated for the following reasons:
research showed the vax was mRNA;
personal opinion was that mRNA could have ability to alter DNA;
it was an experimental drug that did not go through normal testing processes;
it was rushed through FDA approval; and
Nada’s faith in God is based on the fact that God created their DNA 100% perfect, and was not to be altered by any person or thing.
VAX - PFIZER & REDESIVIR
Pfizer, the first jab on the market, that was pushed through development and approval by former US President Donald Trump, now also manufacturers remdesivir on behalf of its French owner Gilead.
As such, Pfizer, that makes the jab for peoples throughout the world, now also makes the poison that has a death rate of 53.1%, for all the peoples in hospitals throughout the world.
Remdesivir was made the global covid hospital protocol, while all other drugs such as ivermectin were banned.
As such hospitals give people a poison that has a death rate of 53.1%, and when persons die, reports them as a “covid deaths”.
For more info, click the link to Global Events page:
National Covid-19 Clinical Evidence Taskforce Australian Guidelines
for the clinical care of people with Covid-19
Australian guidelines clearly states remdesivir is for patients who do not require ventilation. Frank was given remdesivir despite being on a ventilator during his entire hospitalisation.
Frank was given remdesivir contrary to these guidelines.
https://app.magicapp.org/#/guideline/L4Q5An/section/no6vGL
Australian Therapeutic Goods Administration (TGA)
INFORMED CONSENT
According to the TGA, remdesivir is an experimental drug, only provisionally approved for use to treat covid.
Due to its “experimental” status, hospitals and doctors are obligated to obtain informed consent from the patient and/or the patient’s next of kin, which requires the doctor to outline risks and benefits of its use. Further, informed consent is required due to the limited data available on adverse effects and mortality as a consequence of being given the drug.
Canberra Hospital refused to seek or obtain informed consent and administered remdesivir to Frank on their own accord within hours of admission.
The risk of remdesivir is death.
The documented benefit of remdesivir: It may reduce hospitalisation from 15 days to 11 days.
So the question must be posed, would you accept a drug, that fits the definition of “poison” that could kill you by 53%, to reduce your hospital stay by 4 days?
Nada would never have given consent for Frank to be given remdesivir.
Nada was not given a choice.
The hospital doctors took the risk of death.
Frank is now dead.
It is deplorable remdesivir is the global hospital covid protocol, and the Australian hospital protocol in consideration it is:
a drug that was rejected for use to treat ebola following trials;
a drug that has a documented death rate of 53%; and
a drug that has a long list of serious adverse effects.
